Revolution Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RVMD and other ETFs, options, and stocks.About RVMD
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway.
CEOMark A. Goldsmith
CEOMark A. Goldsmith
Employees534
Employees534
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2004
Founded2004
Employees534
Employees534
RVMD Key Statistics
Market cap20.80B
Market cap20.80B
Price-Earnings ratio-20.73
Price-Earnings ratio-20.73
Dividend yield—
Dividend yield—
Average volume4.20M
Average volume4.20M
High today$132.03
High today$132.03
Low today$92.75
Low today$92.75
Open price$95.20
Open price$95.20
Volume13.61M
Volume13.61M
52 Week high$132.03
52 Week high$132.03
52 Week low$29.17
52 Week low$29.17
Stock Snapshot
As of today, Revolution Medicines(RVMD) shares are valued at $121.70. The company's market cap stands at 20.8B, with a P/E ratio of -20.73.
During the trading session on 2026-01-09, Revolution Medicines(RVMD) shares reached a daily high of $132.03 and a low of $92.75. At a current price of $121.70, the stock is +31.2% higher than the low and still -7.8% under the high.
Trading activity shows a volume of 13.61M, compared to an average daily volume of 4.2M.
The stock's 52-week range extends from a low of $29.17 to a high of $132.03.
The stock's 52-week range extends from a low of $29.17 to a high of $132.03.
Analyst ratings
100%
of 20 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own RVMD. This list is generated using Robinhood data, and it’s not a recommendation.